Filling the need for trusted information on national health issues…

Drug Resistance

  • Your Selections:

Refine Results

date

Tags

Third Blog Post In Series Examines China’s History Of Artemisinin Drug Development

Council on Foreign Relation’s “Asia Unbound”: Artemisinin’s Rocky Road to Globalization: Part III In part three of his series on anti-malarial artemisinin drugs, Yanzhong Huang, CFR senior fellow for global health, explores China’s efforts to increase its market share of artemisinin-based combination therapies worldwide. “…To sum up, China has come…

Second Blog Post In Series Examines China’s History Of Artemisinin Drug Development

Council on Foreign Relation’s “Asia Unbound”: Artemisinin’s Rocky Road to Globalization: Part II In part two of his series on anti-malarial artemisinin drugs, Yanzhong Huang, CFR senior fellow for global health, explores the challenges China faced in marketing its artemisinin-based combination therapies worldwide. “…The 2004-2006 artemisinin bubble nevertheless has not…

IBT Examines Strategies Aimed At Promoting Antibiotic Drug Development

International Business Times: Antibiotic Resistance: Why Aren’t Drug Companies Developing New Medicines To Stop Superbugs? “…[A]s many as 10 million people a year could die from antibiotic-resistant bacteria worldwide by 2050 if new treatments are not discovered, according to a recent report from the Review on Antimicrobial Resistance. … Despite…

First Blog Post In Series Examines History Of Artemisinin Development

Council on Foreign Relations’ “Asia Unbound”: Artemisinin’s Rocky Road to Globalization: Part I Yanzhong Huang, CFR senior fellow for global health, examines the history of artemisinin drug development in China during the Cold War era. “…It would take another two decades before [artemisinin-combination therapies (ACTs)] were officially adopted by the…

Artemisinin-Resistant Malaria More Widespread In Asia Than Previously Thought, Research Shows

News outlets discuss a study and commentary regarding the spread of drug-resistant malaria in Asia published in The Lancet Infectious Diseases. Agence France-Presse: Drug-resistant malaria parasite spreading “Parasites resistant to the frontline malaria drug have spread westward from southeast Asia to just short of the Indian border — a gateway…

More Focused Approach Needed To Eliminate Malaria, Avoid Drug Resistance, Researchers Say

Wall Street Journal: A Warning From the Heart of Malaria Research “…[Dr. Nick White, chair of the Wellcome Trust Southeast Asian tropical medicine research units,] and others again are gravely concerned that without a push for eradication soon, enough malarial parasites will become resistant to artemisinin that elimination of the…

Increased Private, Government Investment Needed To Address Antimicrobial Resistance

Project Syndicate: A Call to Antimicrobial Arms Jim O’Neill, honorary professor of economics at Manchester University, visiting research fellow at Bruegel, and fellow of the University of Cambridge’s Center for Rising Powers “…[W]e do not invest enough in research and development. … That is why I am calling on international…

Blog Post Examines U.K. Government Reports On Antibiotic Resistance

WIRED’s “SUPERBUG”: How To Fight Superbugs: Start Spending Money In her blog, journalist Maryn McKenna discusses two recently released reports from the U.K. government on efforts to fight antibiotic resistance. “The government-chartered British project examining antibiotic resistance — which made such a splash in December with its prediction that untreatable…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.